[go: up one dir, main page]

Synthesis of novel triterpenoid (lupeol) derivatives and their in vivo antihyperglycemic and antidyslipidemic activity

Bioorg Med Chem Lett. 2009 Aug 1;19(15):4463-6. doi: 10.1016/j.bmcl.2009.05.034. Epub 2009 May 15.

Abstract

The triterpenoid, lupeol (1) has been isolated from the leaves extract of Aegle marmelos. Few novel derivatives (2-13) were synthesized from the naturally occurring lupeol (1) and screened for their antihyperglycemic activity (2-11) and antidyslipidemic activity (2-4 and 12-13). The derivative 4 lowered the blood glucose levels by 18.2% and 25.0% at 5h and 24h, respectively, in sucrose challenged streptozotocin induced diabetic rats (STZ-S) model at the dose of 100mg/kg body weight. The compound 4 also significantly lowered 40% (P <0.001) in triglycerides, 30% (P <0.05) in glycerol, 24% (P <0.05) in cholesterol quantity and also improved the HDL-cholesterol by 5% in dyslipidemic hamster model at the dose of 50mg/kg b.wt.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / chemical synthesis
  • Anti-Inflammatory Agents / pharmacology
  • Body Weight
  • Chemistry, Pharmaceutical / methods
  • Cricetinae
  • Diabetes Mellitus, Experimental / drug therapy
  • Drug Design
  • Glucose / metabolism
  • Hypoglycemic Agents / chemical synthesis*
  • Hypoglycemic Agents / pharmacology
  • Hypolipidemic Agents / chemical synthesis*
  • Hypolipidemic Agents / pharmacology
  • Models, Chemical
  • Pentacyclic Triterpenes
  • Rats
  • Streptozocin
  • Triglycerides / chemistry
  • Triterpenes / chemical synthesis*
  • Triterpenes / pharmacology

Substances

  • Anti-Inflammatory Agents
  • Hypoglycemic Agents
  • Hypolipidemic Agents
  • Pentacyclic Triterpenes
  • Triglycerides
  • Triterpenes
  • Streptozocin
  • Glucose
  • lupeol